Pharmaceutical Stability and Storage Services Market

研究執行與發布：Grand View Research　·　發布日期 2026-08-07　·　0.065 頁
由量子訊息有限公司（Quantum Information）在台灣代理銷售與提供授權諮詢。

完整報告名稱與涵蓋範圍

Pharmaceutical Stability and Storage Services Market Size, Share & Trends Analysis Report By Service (Stability, Storage), By Molecule (Small, Large), By Region (North America, Europe, Asia Pacific, Latin America, MEA), And Segment Forecasts, 2026 - 2033

報告摘要

Pharmaceutical Stability And Storage Services Market Summary The global pharmaceutical stability and storage services market size was valued at USD 2.0 billion in 2025 and is projected to grow from USD 2.2 billion in 2026 to USD 3.4 billion by 2033, at a CAGR of 6.5% from 2026 to 2033. The market in North America dominated with a revenue share of 40.1% in 2025. Market growth is driven by expanding drug development pipelines, increasing production of biologics & advanced therapies, and mandatory regulatory requirements for shelf-life and storage validation. Other factors contributing to market growth include rising outsourcing by pharmaceutical and biotechnology companies, increasing clinical trial activity, greater demand for cold- and ultra-low-temperature storage, recurring commercial stability programs, packaging and formulation changes, and the adoption of digital monitoring and compliant sample-management systems. Global Pharmaceutical Stability And Storage Services Market Report This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global pharmaceutical stability and storage services market report based on service, molecule, and region. • Service Outlook (Revenue, USD Million, 2021 - 2033) • Stability o Drug Substance o Stability Indicating Method Validation o Accelerated Stability Testing o Photostability Testing o Other Stability Testing Methods • Storage o Cold o Non-cold • Molecule Outlook (Revenue, USD Million, 2021 - 2033) • Small Molecule o Research Products o Commercial Products • Large Molecule o Research Products o Commercial Products • Regional Outlook (Revenue, USD Million, 2021 - 2033) • North America o U.S. o Canada o Mexico • Europe o UK o Germany o France o Italy o Spain o Denmark o Sweden o Norway • Asia Pacific o China o India o Japan o Australia o South Korea o Thailand • Latin America o Brazil o Argentina • Middle East & Africa o South Africa o UAE o Saudi Arabia o Kuwait o Qatar o Oman

授權報價

Single User License	$5,950 USD
Enterprise License	$6,950 USD
Corporate User License	$8,950 USD

目錄 Table of Contents

Table of Contents Chapter 1. Research Methodology and Scope 1.1. Market Segmentation & Scope 1.2. Segment Definitions 1.2.1. Service 1.2.2. Molecule 1.3. Research Methodology 1.4. Information Procurement 1.4.1. Purchased Database 1.4.2. GVR’s Internal Database 1.4.3. Secondary Sources 1.4.4. Primary Research 1.5. Information Or Data Analysis 1.5.1. Data Analysis Models 1.6. Market Formulation & Validation 1.7. Model Details 1.7.1. Commodity Flow Analysis 1.7.2. Top-Down Analysis 1.7.3. Bottom-Up Approach 1.7.4. Multivariate Analysis 1.8. List Of Secondary Sources 1.9. List Of Abbreviations 1.10. Objectives Chapter 2. Executive Summary 2.1. Market Outlook 2.2. Segment Outlook 2.3. Competitive Insights Chapter 3. Pharmaceutical Stability and Storage Services Market Variables, Trends & Scope 3.1. Market Lineage Outlook 3.1.1. Parent Market Outlook 3.1.2. Related/Ancillary Market Outlook 3.2. Market Dynamics 3.2.1. Market Driver Analysis 3.2.1.1. High R&D Spending of Pharmaceutical & Biotechnology Companies 3.2.1.2. Rising Demand for Outsourcing Stability Testing Due to High Complexity Associated with Drug Stability 3.2.1.3. Growing Demand for Biosimilars 3.2.2. Market Restraint Analysis 3.2.2.1. Strict Regulations for Global Pharmaceutical Stability and Storage Services Drugs 3.2.2.2. Issues Associated with Stability Chambers 3.3. Business Model Analysis 3.4. Technology Landscape 3.5. Pricing Model Analysis 3.6. Tariff and Trade Agreement Impact Analysis 3.7. Industry Ecosystem Analysis 3.8. Market Analysis Tools 3.8.1. Porter’s Five Force Analysis 3.8.2. PESTEL by SWOT Analysis Chapter 4. Pharmaceutical Stability and Storage Services Market: Service Estimates & Trend Analysis 4.1. Pharmaceutical Stability and Storage Services Market, By Service: Segment Dashboard 4.2. Pharmaceutical Stability and Storage Services Market, By Service: Movement Analysis 4.3. Pharmaceutical Stability and Storage Services Market Estimates & Forecasts, By Service, 2021 - 2033 (USD Million) 4.4. Stability 4.4.1. Stability Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.4.2. Drug Substance 4.4.2.1. Drug Substance Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.4.3. Stability Indicating Method Validation 4.4.3.1. Stability Indicating Method Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.4.4. Accelerated Stability Testing 4.4.4.1. Accelerated Stability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.4.5. Photostability Testing 4.4.5.1. Photostability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.4.6. Other Stability Testing Methods 4.4.6.1. Other Stability Testing Methods Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.5. Storage 4.5.1. Storage Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.5.2. Cold 4.5.2.1. Cold Market Estimates and Forecasts, 2021 - 2033 (USD Million) 4.5.3. Non-Cold 4.5.3.1. Non-Cold Market Estimates and Forecasts, 2021 - 2033 (USD Million) Chapter 5. Pharmaceutical Stability and Storage Services Market: Molecule Estimates & Trend Analysis 5.1. Pharmaceutical Stability and Storage Services Market, By Molecule: Segment Dashboard 5.2. Pharmaceutical Stability and Storage Services Market, By Molecule: Movement Analysis 5.3. Pharmaceutical Stability and Storage Services Market Estimates & Forecasts, By Molecule, 2021 - 2033 (USD Million) 5.4. Small Molecule 5.4.1. Small Molecule Market Estimates and Forecasts, 2021 - 2033 (USD Million) 5.4.2. Research Products 5.4.2.1. Research Products Market Estimates and Forecasts, 2021 - 2033 (USD Million) 5.4.3. Commercial Products 5.4.3.1. Commercial Products Market Estimates and Forecasts, 2021 - 2033 (USD Million) 5.5. Large Molecule 5.5.1. Large Molecule Market Estimates and Forecasts, 2021 - 2033 (USD Million) 5.5.2. Research Products 5.5.2.1. Research Products Market Estimates and Forecasts, 2021 - 2033 (USD Million) 5.5.3. Commercial Products 5.5.3.1. Commercial Products Market Estimates and Forecasts, 2021 - 2033 (USD Million) Chapter 6. Pharmaceutical Stability and Storage Services Market: Regional Estimates & Trend Analysis 6.1. Regional Market Dashboard 6.2. Regional Market Share Analysis, 2025 & 2033 6.3. North America 6.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.3.2. U.S 6.3.2.1. Key Country Dynamics 6.3.2.2. Competitive Scenario 6.3.2.3. Regulatory Framework 6.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.3.3. Canada 6.3.3.1. Key Country Dynamics 6.3.3.2. Competitive Scenario 6.3.3.3. Regulatory Framework 6.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.3.4. Mexico 6.3.4.1. Key Country Dynamics 6.3.4.2. Competitive Scenario 6.3.4.3. Regulatory Framework 6.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.4. Europe 6.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.4.2. UK 6.4.2.1. Key Country Dynamics 6.4.2.2. Competitive Scenario 6.4.2.3. Regulatory Framework 6.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.4.3. Germany 6.4.3.1. Key Country Dynamics 6.4.3.2. Competitive Scenario 6.4.3.3. Regulatory Framework 6.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.4.4. France 6.4.4.1. Key Country Dynamics 6.4.4.2. Competitive Scenario 6.4.4.3. Regulatory Framework 6.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.4.5. Italy 6.4.5.1. Key Country Dynamics 6.4.5.2. Competitive Scenario 6.4.5.3. Regulatory Framework 6.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.4.6. Spain 6.4.6.1. Key Country Dynamics 6.4.6.2. Competitive Scenario 6.4.6.3. Regulatory Framework 6.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.4.7. Denmark 6.4.7.1. Key Country Dynamics 6.4.7.2. Competitive Scenario 6.4.7.3. Regulatory Framework 6.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.4.8. Sweden 6.4.8.1. Key Country Dynamics 6.4.8.2. Competitive Scenario 6.4.8.3. Regulatory Framework 6.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.4.9. Norway 6.4.9.1. Key Country Dynamics 6.4.9.2. Competitive Scenario 6.4.9.3. Regulatory Framework 6.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.5. Asia Pacific 6.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.5.2. China 6.5.2.1. Key Country Dynamics 6.5.2.2. Competitive Scenario 6.5.2.3. Regulatory Framework 6.5.2.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.5.3. India 6.5.3.1. Key Country Dynamics 6.5.3.2. Competitive Scenario 6.5.3.3. Regulatory Framework 6.5.3.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.5.4. Japan 6.5.4.1. Key Country Dynamics 6.5.4.2. Competitive Scenario 6.5.4.3. Regulatory Framework 6.5.4.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.5.5. Australia 6.5.5.1. Key Country Dynamics 6.5.5.2. Competitive Scenario 6.5.5.3. Regulatory Framework 6.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.5.6. South Korea 6.5.6.1. Key Country Dynamics 6.5.6.2. Competitive Scenario 6.5.6.3. Regulatory Framework 6.5.6.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.5.7. Thailand 6.5.7.1. Key Country Dynamics 6.5.7.2. Competitive Scenario 6.5.7.3. Regulatory Framework 6.5.7.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.6. Latin America 6.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.6.2. Brazil 6.6.2.1. Key Country Dynamics 6.6.2.2. Competitive Scenario 6.6.2.3. Regulatory Framework 6.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.6.3. Argentina 6.6.3.1. Key Country Dynamics 6.6.3.2. Competitive Scenario 6.6.3.3. Regulatory Framework 6.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.7. MEA 6.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.7.2. South Africa 6.7.2.1. Key Country Dynamics 6.7.2.2. Competitive Scenario 6.7.2.3. Regulatory Framework 6.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.7.3. UAE 6.7.3.1. Key Country Dynamics 6.7.3.2. Competitive Scenario 6.7.3.3. Regulatory Framework 6.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.7.4. Saudi Arabia 6.7.4.1. Key Country Dynamics 6.7.4.2. Competitive Scenario 6.7.4.3. Regulatory Framework 6.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.7.5. Kuwait 6.7.5.1. Key Country Dynamics 6.7.5.2. Competitive Scenario 6.7.5.3. Regulatory Framework 6.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.7.6. Qatar 6.7.6.1. Key Country Dynamics 6.7.6.2. Competitive Scenario 6.7.6.3. Regulatory Framework 6.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million) 6.7.7. Oman 6.7.7.1. Key Country Dynamics 6.7.7.2. Competitive Scenario 6.7.7.3. Regulatory Framework 6.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million) Chapter 7. Competitive Landscape 7.1. Key Participant Categorization 7.1.1. Market Leaders 7.1.2. Emerging Players 7.2. Market Assessment Analysis, 2025 (Heat Map Analysis) 7.3. Company Profiles 7.3.1. Catalent, Inc 7.3.1.1. Company Overview 7.3.1.2. Financial Performance 7.3.1.3. Service Benchmarking 7.3.1.4. Strategic Initiatives 7.3.2. Almac Group 7.3.2.1. Company Overview 7.3.2.2. Financial Performance 7.3.2.3. Service Benchmarking 7.3.2.4. Strategic Initiatives 7.3.3. Charles River Laboratories 7.3.3.1. Company Overview 7.3.3.2. Financial Performance 7.3.3.3. Service Benchmarking 7.3.3.4. Strategic Initiatives 7.3.4. Eurofins Scientific 7.3.4.1. Company Overview 7.3.4.2. Financial Performance 7.3.4.3. Service Benchmarking 7.3.4.4. Strategic Initiatives 7.3.5. Intertek Group plc 7.3.5.1. Company Overview 7.3.5.2. Financial Performance 7.3.5.3. Service Benchmarking 7.3.5.4. Strategic Initiatives 7.3.6. Lucideon Limited 7.3.6.1. Company Overview 7.3.6.2. Financial Performance 7.3.6.3. Service Benchmarking 7.3.6.4. Strategic Initiatives 7.3.7. Alcami Corporation 7.3.7.1. Company Overview 7.3.7.2. Financial Performance 7.3.7.3. Service Benchmarking 7.3.7.4. Strategic Initiatives 7.3.8. Element Materials Technology 7.3.8.1. Company Overview 7.3.8.2. Financial Performance 7.3.8.3. Service Benchmarking 7.3.8.4. Strategic Initiatives 7.3.9. BioLife Solutions Inc. 7.3.9.1. Company Overview 7.3.9.2. Financial Performance 7.3.9.3. Service Benchmarking 7.3.9.4. Strategic Initiatives 7.3.10. Q1 Scientific 7.3.10.1. Company Overview 7.3.10.2. Financial Performance 7.3.10.3. Service Benchmarking 7.3.10.4. Strategic Initiatives 7.3.11. Reading Scientific Services Ltd. 7.3.11.1. Company Overview 7.3.11.2. Financial Performance 7.3.11.3. Service Benchmarking 7.3.11.4. Strategic Initiatives 7.3.12. Roylance Stability Storage Limited 7.3.12.1. Company Overview 7.3.12.2. Financial Performance 7.3.12.3. Service Benchmarking 7.3.12.4. Strategic Initiatives 7.3.13. ALS 7.3.13.1. Company Overview 7.3.13.2. Financial Performance 7.3.13.3. Service Benchmarking 7.3.13.4. Strategic Initiatives 7.3.14. Q Laboratories 7.3.14.1. Company Overview 7.3.14.2. Financial Performance 7.3.14.3. Service Benchmarking 7.3.14.4. Strategic Initiatives 7.3.15. Auriga Research Private Limited 7.3.15.1. Company Overview 7.3.15.2. Financial Performance 7.3.15.3. Service Benchmarking 7.3.15.4. Strategic Initiatives 7.3.16. PD Partners 7.3.16.1. Company Overview 7.3.16.2. Financial Performance 7.3.16.3. Service Benchmarking 7.3.16.4. Strategic Initiatives 7.3.17. Precision Stability Storage 7.3.17.1. Company Overview 7.3.17.2. Financial Performance 7.3.17.3. Service Benchmarking 7.3.17.4. Strategic Initiatives 7.3.18. SGS Société Générale de Surveillance SA. 7.3.18.1. Company Overview 7.3.18.2. Financial Performance 7.3.18.3. Service Benchmarking 7.3.18.4. Strategic Initiatives

圖表清單 List of Tables & Figures

List of Tables Table 1 List of Secondary Sources Table 2 List of Abbreviations Table 3 Global Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 4 Global Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 5 North America Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million) Table 6 North America Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 7 North America Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 8 U.S Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 9 U.S Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 10 Canada Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 11 Canada Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 12 Mexico Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 13 Mexico Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 14 Europe Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million) Table 15 Europe Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 16 Europe Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 17 UK Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 18 UK Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 19 Germany Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 20 Germany Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 21 France Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 22 France Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 23 Italy Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 24 Italy Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 25 Spain Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 26 Spain Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 27 Denmark Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 28 Denmark Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 29 Sweden Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 30 Sweden Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 31 Norway Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 32 Norway Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 33 Asia Pacific Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million) Table 34 Asia Pacific Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 35 Asia Pacific Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 36 China Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 37 China Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 38 India Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 39 India Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 40 Japan Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 41 Japan Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 42 Australia Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 43 Australia Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 44 South Korea Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 45 South Korea Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 46 Thailand Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 47 Thailand Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 48 Latin America Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million) Table 49 Latin America Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 50 Brazil Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 51 Brazil Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 52 Argentina Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 53 Argentina Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 54 Middle East & Africa Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Country, 2021 - 2033 (USD Million) Table 55 Middle East & Africa Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 56 South Africa Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 57 South Africa Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 58 Saudi Arabia Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 59 Saudi Arabia Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 60 UAE Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 61 UAE Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 62 Kuwait Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 63 Kuwait Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 64 Oman Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 65 Oman Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) Table 66 Qatar Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Service, 2021 - 2033 (USD Million) Table 67 Qatar Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, by Molecule, 2021 - 2033 (USD Million) List of Figures Fig. 1 Market research process Fig. 2 Information procurement Fig. 3 Primary research pattern Fig. 4 Market research approaches Fig. 5 Market formulation & validation Fig. 6 Commodity flow analysis Fig. 7 Value-chain-based sizing & forecasting Fig. 8 QFD model sizing & forecasting Fig. 9 Bottom-up approach Fig. 10 Market snapshot Fig. 11 Segment snapshot 1 Fig. 12 Segment snapshot 2 Fig. 13 Competitive landscape snapshot Fig. 14 Parent market outlook, 2025 (USD Billion) Fig. 15 Ancillary market outlook, 2025 (USD Billion) Fig. 16 Pharmaceutical Stability and Storage Services Market Dynamics Fig. 17 Porter’s Five Forces Analysis Fig. 18 PESTEL Analysis Fig. 19 Pharmaceutical Stability and Storage Services Market: Service outlook and key takeaways Fig. 20 Pharmaceutical Stability and Storage Services Market: Service movement analysis Fig. 21 Stability Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 22 Drug Substance Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 23 Stability Indicating Method Validation Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 24 Accelerated Stability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 25 Photostability Testing Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 26 Other Stability Testing Methods Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 27 Storage Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 28 Cold Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 29 Non-Cold Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 30 Pharmaceutical Stability and Storage Services Market: Molecule outlook and key takeaways Fig. 31 Pharmaceutical Stability and Storage Services Market: Molecule movement analysis Fig. 32 Small Molecule Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 33 Research Products Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 34 Commercial Products Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 35 Large Molecule Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 36 Research Products Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 37 Commercial Products Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 38 Regional Marketplace: Key Takeaways Fig. 39 North America Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021–2033 (USD Million) Fig. 40 Key Country Dynamics Fig. 41 U.S. Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 42 Key Country Dynamics Fig. 43 Canada Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 44 Key Country Dynamics Fig. 45 Mexico Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 46 Europe Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 47 Key Country Dynamics Fig. 48 UK Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 49 Key Country Dynamics Fig. 50 Germany Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 51 Key Country Dynamics Fig. 52 France Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 53 Key Country Dynamics Fig. 54 Italy Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 55 Key Country Dynamics Fig. 56 Spain Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 57 Key Country Dynamics Fig. 58 Denmark Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 59 Key Country Dynamics Fig. 60 Sweden Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 61 Key Country Dynamics Fig. 62 Norway Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 63 Asia Pacific Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 64 Key Country Dynamics Fig. 65 China Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 66 Key Country Dynamics Fig. 67 India Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 68 Key Country Dynamics Fig. 69 Japan Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 70 Key Country Dynamics Fig. 71 Australia Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 72 Key Country Dynamics Fig. 73 South Korea Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 74 Key Country Dynamics Fig. 75 Thailand Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 76 Latin America Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 77 Key Country Dynamics Fig. 78 Brazil Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 79 Key Country Dynamics Fig. 80 Argentina Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 81 MEA Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 82 Key Country Dynamics Fig. 83 South Africa Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 84 Key Country Dynamics Fig. 85 UAE Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 86 Key Country Dynamics Fig. 87 Saudi Arabia Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 88 Key Country Dynamics Fig. 89 Kuwait Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 90 Key Country Dynamics Fig. 91 Qatar Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million) Fig. 92 Key Country Dynamics Fig. 93 Oman Pharmaceutical Stability and Storage Services Market Estimates and Forecasts, 2021 - 2033 (USD Million)

提及公司

Catalent, IncAlmac GroupCharles River LaboratoriesEurofins ScientificIntertek Group plcLucideon LimitedAlcami CorporationElement Materials TechnologyBioLife Solutions Inc.Q1 ScientificReading Scientific Services Ltd.Roylance Stability Storage LimitedALSQ LaboratoriesAuriga Research Private LimitedPD PartnersPrecision Stability StorageSGS Société Générale de Surveillance SA.

常見問題

這份報告可以先索取樣本嗎？

可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。

報告價格如何計算？

報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。

下單後多久交付？如何付款？

一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。

量子訊息有限公司為 Grand View Research 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・聯絡我們